Key result
Secondary thrombophilia in children was associated with a 10% recurrence rate compared to 30% for primary thrombophilia, and presented mostly with neurological symptoms.
Why the study?
What are the clinical features, etiologies, and outcomes of childhood thrombosis in a pediatric hematology-oncology unit?
Cohort (n=30)
No
What are the clinical features, etiologies, and outcomes of childhood thrombosis in a pediatric hematology-oncology unit?
Childhood thrombosis in a pediatric hematology-oncology setting is most commonly secondary to acquired risk factors like cancer chemotherapy, presenting frequently with neurological symptoms.
Answers are grounded in this paper and cite their sources.
May support etiology-specific risk stratification in pediatric thrombosis; leaves open need for prospective validation before guiding management.
Aim of the study: Thrombosis is rare in childhood with limited studies. Our retrospective study was designed to evaluate children with documented thrombotic events registered in our pediatric hematology -oncology unit over the last 3 years as regards clinical features, etiology, management and outcomes. Methods: Among 963 newly registered, 30 patients (16 females and 14 males, median age 4.5 years) with clinical and radiological evidence of thrombosis were identified. Data collection included clinical presentation, identifiable risk factors, thrombophilia screening, radiologic investigations, treatment and outcome. Results: Age at first thrombotic event was higher for patients with secondary than primary etiology (p=0.018). In 66.7% of patients, there was at least one identified risk for thrombosis, and cancer chemotherapy was the most frequent etiology. Inherited thrombophilia were proven in 13.3%. Secondary thrombophilia presented mostly with neurological symptoms (70%) while inherited thrombophilias with purpura fulminans (80%) (p=0.001). The recurrence was higher with primary (30%) compared to secondary Original Research Article British Journal of Medicine & Medical Research, 4(3): 873-882, 2014 874 thrombophilias (10%). Patients' outcome included neurologic deficit (26.7%), recurrence (16.7%), amputation (6.7%) and death (16.7%). Conclusion: Thrombosis secondary to an acquired risk factor occurred at older age, commonly presented by central thrombosis with no significant difference between primary and secondary thrombosis in the residual effects. Further studies are warranted to determine proper duration of anticoagulant therapy to prevent recurrence.
No takes yet. Share an insight, caveat, or question.
Mokhtar et al. (2013) conducted a cohort in Childhood Thrombosis (n=30). Secondary thrombophilia vs. Primary thrombophilia was evaluated on Recurrence of thrombosis. Secondary thrombophilia in children was associated with a 10% recurrence rate compared to 30% for primary thrombophilia, and presented mostly with neurological symptoms.
Synapse has enriched 10 related papers. Consider them for comparative context: